Registrati | Log in | FAQ      [?] 
Recent | Unread | Search | Authors | Tags | Export

di jyuh acei [95 articles]

Articoli aggiunti di recente alla biblioteca di jyuh classificati sotto il tag acei. You can also see everyone's acei.
  • Rationale, design, and baseline characteristics of 2 large, simple, randomized trials evaluating telmisartan, ramipril, and their combination in high-risk patients: the Ongoing Telmisartan Alone and in Combination with Ramipril Global Endpoint Trial/Telmisartan Randomized Assessment Study in ACE Intolerant Subjects with Cardiovascular Disease (ONTARGET/TRANSCEND) trials.
    American heart journal, Vol. 148, No. 1. (July 2004), pp. 52-61.
    by K Teo, S Yusuf, P Sleight, C Anderson, F Mookadam, B Ramos, L Hilbrich, J Pogue, H Schumacher,
    posted to rct cv arb aceiarb acei by jyuh on 2008-10-07 09:39:52 as **
  • Inhibition of renin angiotensin system decreases renal protein oxidative damage in diabetic rats.
    Biochemical and biophysical research communications, Vol. 368, No. 3. (11 April 2008), pp. 528-535.
    by M Portero-Otín, R Pamplona, J Boada, M Jové, H Gonzalo, M Buleon, W Linz, S Schäfer, I Tack, JP Girolami
    posted to ros dn arb aii acei by jyuh on 2008-10-04 02:35:29 as **
  • Effect of Renin-Angiotensin-Aldosterone System Inhibition, Dietary Sodium Restriction, and/or Diuretics on Urinary Kidney Injury Molecule 1 Excretion in Nondiabetic Proteinuric Kidney Disease: A Post Hoc Analysis of a Randomized Controlled Trial.
    American journal of kidney diseases : the official journal of the National Kidney Foundation (25 September 2008)
    by Femke Waanders, Vishal S S Vaidya, Harry van V Goor, Henri Leuvenink, Kevin Damman, Inge Hamming, Joseph V V Bonventre, Liffert Vogt, Gerjan Navis
    posted to urine salt rct nondn kim1 diuretics arb acei by jyuh on 2008-10-03 04:06:01 as **
  • Blocking the renin-angiotensin-aldosterone system to prevent diabetes mellitus.
    Diabetes & vascular disease research : official journal of the International Society of Diabetes and Vascular Disease, Vol. 5, No. 1. (March 2008), pp. 59-66.
    by DK McGuire, JR Winterfield, JA Rytlewski, E Ferrannini
    posted to prevention dm arb acei by jyuh on 2008-10-02 16:33:23 as **
  • The cost-effectiveness of treating all patients with type 2 diabetes with angiotensin-converting enzyme inhibitors.
    Annals of internal medicine, Vol. 131, No. 9. (2 November 1999), pp. 660-667.
    by L Golan, JD Birkmeyer, HG Welch
    posted to dm cea acei 1 by jyuh on 2008-10-02 11:04:49 as **
  • Review: effectiveness of ACE inhibitors is similar across various baseline risks for disease progression in nondiabetic nephropathy.
    ACP journal club, Vol. 148, No. 1. (b 2008)
    by M Laville
    posted to nondn acei by jyuh on 2008-10-02 11:02:37 as **
  • Urine protein profile of IgA nephropathy patients may predict the response to ACE-inhibitor therapy.
    Proteomics, Vol. 8, No. 1. (January 2008), pp. 206-216.
    by MT Rocchetti, M Centra, M Papale, G Bortone, C Palermo, D Centonze, E Ranieri, S Di Paolo, L Gesualdo
    posted to snp proteinuria gn acei by jyuh on 2008-10-02 11:01:09 as **
  • The role of renin-angiotensin-aldosterone system-based therapy in diabetes prevention and cardiovascular and renal protection.
    Diabetes, obesity & metabolism (20 May 2008)
    by Hussam Abuissa, James O'Keefe
    posted to dm cv ckd arb acei by jyuh on 2008-10-01 03:27:12 as **
  • Effect of eplerenone, enalapril and their combination treatment on diabetic nephropathy in type II diabetic rats.
    Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association (5 August 2008)
    by Young Sun S Kang, Gang Jee J Ko, Mi Hwa H Lee, Hye Kyoung K Song, Sang Youb Y Han, Kum Hyun H Han, Hyoung Kyu K Kim, Jee Young Y Han, Dae Ryong R Cha
    posted to rat dn aldosterone acei by jyuh on 2008-09-26 16:59:57 as **
  • Tissue angiotensin-converting enzyme inhibitors for the prevention of cardiovascular disease in patients with diabetes mellitus without left ventricular systolic dysfunction or clinical evidence of heart failure: a pooled meta-analysis of randomized placebo-controlled clinical trials
    Diabetes, Obesity and Metabolism, Vol. 10, No. 1. (January 2008), pp. 41-52.
    by Saha, , Molnar, , Arora,
    posted to rct meta-analysis dm cv arb acei by jyuh on 2008-09-25 10:02:11 as **
  • Insight into ACE inhibition in the prevention of cardiac events in stable coronary artery disease: the EUROPA trial
    Expert Review of Cardiovascular Therapy, Vol. 5, No. 6. (November 2007), pp. 1037-1046.
    by Ferrari, Roberto, Bertrand, E Michel, Remme, J Willem, Simoons, L Maarten, Deckers, W Jaap, Fox, M Kim
    posted to rct perindopril cv acei by jyuh on 2008-09-25 09:58:32 as **
  • Treatment with angiotensin-converting enzyme inhibitors: insight into perindopril cardiovascular protection
    posted to rct perindopril cv acei by jyuh on 2008-09-25 09:33:10 as **
  • Renal function and effectiveness of angiotensin-converting enzyme inhibitor therapy in patients with chronic stable coronary disease in the Prevention of Events with ACE inhibition (PEACE) trial.
    Circulation, Vol. 114, No. 1. (4 July 2006), pp. 26-31.
    by SD Solomon, MM Rice, K A Jablonski, P Jose, M Domanski, M Sabatine, BJ Gersh, J Rouleau, MA Pfeffer, E Braunwald,
    posted to rct ckd acei by jyuh on 2008-09-25 09:14:08 as **
  • Angiotensin inhibition in renovascular disease: a population-based cohort study.
    American heart journal, Vol. 156, No. 3. (September 2008), pp. 549-555.
    by DG Hackam, ML Duong-Hua, M Mamdani, P Li, SW Tobe, JD Spence, AX Garg
    posted to hospitalization cv ckd arf arb acei by jyuh on 2008-09-25 08:23:02 as **
  • Effects of the angiotensin-receptor blocker telmisartan on cardiovascular events in high-risk patients intolerant to angiotensin-converting enzyme inhibitors: a randomised controlled trial.
    Lancet (29 August 2008)
    by
    posted to rct cv arb acei 1 by jyuh on 2008-09-25 08:18:17 as **
  • Renal outcomes with telmisartan, ramipril, or both, in people at high vascular risk (the ONTARGET study): a multicentre, randomised, double-blind, controlled trial.
    Lancet, Vol. 372, No. 9638. (16 August 2008), pp. 547-553.
    by JF Mann, RE Schmieder, M McQueen, L Dyal, H Schumacher, J Pogue, X Wang, A Maggioni, A Budaj, S Chaithiraphan, K Dickstein, M Keltai, K Metsärinne, A Oto, A Parkhomenko, LS Piegas, TL Svendsen, KK Teo, S Yusuf,
    posted to rct dn cv arb aceiarb acei 1 by jyuh on 2008-09-25 08:05:33 as ** along with 1 person blr251
  • Are two better than one? Angiotensin-converting enzyme inhibitors plus angiotensin receptor blockers for reducing blood pressure and proteinuria in kidney disease.
    Clinical journal of the American Society of Nephrology : CJASN, Vol. 3 Suppl 1 (January 2008)
    by SL Linas
    posted to ckd arb aceiarb acei by jyuh on 2008-09-13 09:13:12 as **
  • Randomised placebo-controlled trial of effect of ramipril on decline in glomerular filtration rate and risk of terminal renal failure in proteinuric, non-diabetic nephropathy. The GISEN Group (Gruppo Italiano di Studi Epidemiologici in Nefrologia)
    Lancet, Vol. 349, No. 9069. (28 June 1997), pp. 1857-1863.
    posted to rct proteinuria ckd acei by jyuh on 2008-09-13 08:55:25 as ** along with 1 person brainsman2000
  • Angiotensin receptor blockers: RAAS blockade and renoprotection
    Current Medical Research and Opinion, Vol. 24, No. 5. (May 2008), pp. 1285-1293.
    by Ruilope, M Luis
    posted to ckd arb acei by jyuh on 2008-09-13 08:38:15 as **
  • Combination therapy with renin-angiotensin system inhibitors and the calcium channel blocker azelnidipine decreases plasma inflammatory markers and urinary oxidative stress markers in patients with diabetic nephropathy.
    Hypertension research : official journal of the Japanese Society of Hypertension, Vol. 31, No. 6. (June 2008), pp. 1147-1155.
    by S Ogawa, T Mori, K Nako, S Ito
    posted to dn ccb arb acei by jyuh on 2008-09-07 06:06:49 as **
  • Renal pro-inflammatory cytokine gene expression in diabetic nephropathy: effect of angiotensin-converting enzyme inhibition and pentoxifylline administration.
    American journal of nephrology, Vol. 26, No. 6. (2006), pp. 562-570.
    by JF Navarro, FJ Milena, C Mora, C León, J García
    posted to pentoxifylline inflammation dn cytokine acei by jyuh on 2008-09-04 06:19:42 as **
  • Angiotensin-converting enzyme gene polymorphism predicts the time-course of blood pressure response to angiotensin converting enzyme inhibition in the AASK trial.
    Journal of hypertension, Vol. 25, No. 10. (October 2007), pp. 2082-2092.
    by V Bhatnagar, DT O'Connor, NJ Schork, RM Salem, CM Nievergelt, BK Rana, DW Smith, GL Bakris, JP Middleton, KC Norris, JT Wright, D Cheek, L Hiremath, G Contreras, LJ Appel, MS Lipkowitz
    posted to ace acei bp snp by jyuh on 2008-08-16 07:54:33 as **
  • Correlates of ACE activity in macroalbuminuric type 2 diabetic patients treated with chronic ACE inhibition.
    Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, Vol. 23, No. 4. (April 2008), pp. 1274-1277.
    by A Nikzamir, M Nakhjavani, A Esteghamati, A Rashidi
    posted to ace acei dn snp by jyuh on 2008-08-12 08:38:20 as **
  • Concomitant calcium entry blockade and inhibition of the renin-angiotensin system: a rational and effective means for treating hypertension.
    Journal of the renin-angiotensin-aldosterone system : JRAAS, Vol. 9, No. 1. (March 2008), pp. 1-9.
    by B Gojanovic, F Feihl, L Liaudet, B Waeber
    posted to acei arb bp ccb by jyuh on 2008-07-21 05:49:29 as **
  • Angiotensin receptor blockers versus angiotensin-converting enzyme inhibitors: where do we stand now?
    The American journal of cardiology, Vol. 100, No. 3A. (6 August 2007)
    by M Böhm
    posted to aceiarb acei arb cv rct by jyuh on 2008-07-21 05:03:00 as **
  • The COOPERATE trial: a letter of concern.
    Lancet, Vol. 371, No. 9624. (10 May 2008), pp. 1575-1576.
    by R Kunz, M Wolbers, T Glass, JF Mann
    posted to acei arb meta-analysis rct by jyuh on 2008-07-21 05:00:41 as **
  • Combination treatment of angiotensin-II receptor blocker and angiotensin-converting-enzyme inhibitor in non-diabetic renal disease (COOPERATE): a randomised controlled trial.
    Lancet, Vol. 361, No. 9352. (11 January 2003), pp. 117-124.
    by N Nakao, A Yoshimura, H Morita, M Takada, T Kayano, T Ideura
    posted to aceiarb acei arb ckd rct by jyuh on 2008-07-21 04:47:08 as **
  • Sex differences in response to chronic heart failure therapies
    Expert Review of Cardiovascular Therapy, Vol. 6, No. 4. (April 2008), pp. 555-565.
    by Ghali, K Jalal, Lindenfeld, Joann
    posted to acei arb chf gender by jyuh on 2008-07-21 04:39:52 as **
  • Prognostic impact of angiotensin-converting enzyme inhibitor therapy in diastolic heart failure.
    The American journal of cardiology, Vol. 101, No. 5. (1 March 2008), pp. 639-644.
    by C Tribouilloy, D Rusinaru, L Leborgne, M Peltier, Z Massy, M Slama
    posted to acei chf diastolic mortality by jyuh on 2008-07-21 04:39:14 as **
  • Candesartan in heart failure: assessment of reduction in mortality and morbidity (CHARM) and resource utilization and costs in Italy.
    Vascular health and risk management, Vol. 4, No. 1. (2008), pp. 223-234.
    by GL Colombo, M Caruggi, C Ottolini, AP Maggioni
    posted to cea aceiarb acei arb rct by jyuh on 2008-07-21 04:19:24 as **
  • Efficacy and tolerability of adding an angiotensin receptor blocker in patients with heart failure already receiving an angiotensin-converting inhibitor plus aldosterone antagonist, with or without a beta blocker. Findings from the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM)-Added trial.
    European journal of heart failure : journal of the Working Group on Heart Failure of the European Society of Cardiology, Vol. 10, No. 2. (February 2008), pp. 157-163.
    by RA Weir, JJ McMurray, M Puu, SD Solomon, B Olofsson, CB Granger, S Yusuf, EL Michelson, K Swedberg, MA Pfeffer,
    posted to aceiarb acei arb chf rct by jyuh on 2008-07-21 04:10:12 as **
  • Angiotensin-converting enzyme inhibitors and survival in women and men with heart failure.
    European journal of heart failure : journal of the Working Group on Heart Failure of the European Society of Cardiology, Vol. 9, No. 6-7. (l 2007), pp. 594-601.
    by G Keyhan, SF Chen, L Pilote
    posted to acei chf gender by jyuh on 2008-07-21 03:15:54 as **
  • Sex differences in the effectiveness of angiotensin receptor blockers and angiotensin converting enzyme inhibitors in patients with congestive heart failure--a population study.
    European journal of heart failure : journal of the Working Group on Heart Failure of the European Society of Cardiology, Vol. 9, No. 6-7. (l 2007), pp. 602-609.
    by M Hudson, E Rahme, H Behlouli, R Sheppard, L Pilote
    posted to acei arb chf gender by jyuh on 2008-07-21 03:13:15 as **
  • Blood pressure-dependent and independent effects of agents that inhibit the renin-angiotensin system.
    Journal of hypertension, Vol. 25, No. 5. (May 2007), pp. 951-958.
    by , F Turnbull, B Neal, M Pfeffer, J Kostis, C Algert, M Woodward, J Chalmers, A Zanchetti, S MacMahon
    posted to rct cv bp arb acei by jyuh on 2008-07-21 02:08:23 as **
  • Targeting cardiovascular protection: the concept of dual renin-angiotensin system control.
    Medscape journal of medicine, Vol. 10 Suppl (2008)
    by T Unger, A Jakobsen, J Heroys, A Ralph, T Rees, M Shaw
    posted to aceiarb acei arb by jyuh on 2008-07-21 02:01:04 as **
  • No HOPE without proof: do ARBs meet the standard for cardiovascular protection?
    Medscape journal of medicine, Vol. 10 Suppl (2008)
    by P Sleight, A Jakobsen, J Heroys, A Ralph, T Rees, M Shaw
    posted to rct meta-analysis cv arb acei by jyuh on 2008-07-21 02:00:45 as **
  • Comparison between angiotensin-converting enzyme inhibitors and angiotensin receptor blockers on the risk of myocardial infarction, stroke and death: a meta-analysis.
    Journal of hypertension, Vol. 26, No. 7. (July 2008), pp. 1282-1289.
    by Gianpaolo Reboldi, Fabio Angeli, Claudio Cavallini, Giorgio Gentile, Giuseppe Mancia, Paolo Verdecchia
    posted to acei arb cv meta-analysis mortality stroke by jyuh on 2008-07-21 01:49:35 as **
  • Ace inhibitors as a therapy for sarcopenia - evidence and possible mechanisms.
    The journal of nutrition, health & aging, Vol. 12, No. 7. (July 2008), pp. 480-485.
    by D Sumukadas, MD Witham, AD Struthers, ME McMurdo
    posted to acei cachexia by jyuh on 2008-07-21 01:48:30 as **
  • Reporting on sex-based analysis in clinical trials of angiotensin-converting enzyme inhibitor and angiotensin receptor blocker efficacy.
    The Canadian journal of cardiology, Vol. 24, No. 6. (June 2008), pp. 491-496.
    by DM Rabi, N Khan, M Vallee, MA Hladunewich, SW Tobe, L Pilote
    posted to acei arb gender rct by jyuh on 2008-07-20 15:56:27 as **
  • RAS blockade with ARB and ACE inhibitors: current perspective on rationale and patient selection.
    Clinical research in cardiology : official journal of the German Cardiac Society, Vol. 97, No. 7. (July 2008), pp. 418-431.
    by C Werner, M Baumhäkel, KK Teo, R Schmieder, J Mann, T Unger, S Yusuf, M Böhm
    posted to aceiarb acei arb by jyuh on 2008-07-20 15:55:07 as **
  • Comparison of dual RAAS blockade and higher-dose RAAS inhibition on nephropathy progression.
    Postgraduate medicine, Vol. 120, No. 1. (April 2008), pp. 33-42.
    by GL Bakris, MR Weir
    posted to aceiarb acei arb ckd by jyuh on 2008-07-20 15:17:06 as **
  • Safety and tolerability of angiotensin-converting enzyme inhibitor versus the combination of angiotensin-converting enzyme inhibitor and angiotensin receptor blocker in patients with left ventricular dysfunction: a systematic review and meta-analysis of randomized controlled trials.
    Journal of cardiac failure, Vol. 14, No. 3. (April 2008), pp. 181-188.
    by R Lakhdar, MH Al-Mallah, DE Lanfear
    posted to aceiarb acei arb cv meta-analysis by jyuh on 2008-07-20 15:06:28 as **
  • Renin-angiotensin system inhibitors, angiotensin I-converting enzyme gene insertion/deletion polymorphism, and cancer: the Rotterdam Study.
    Cancer, Vol. 112, No. 4. (15 February 2008), pp. 748-757.
    by R van der Knaap, C Siemes, JW Coebergh, CM van Duijn, A Hofman, BH Stricker
    posted to acei arb cancer by jyuh on 2008-07-14 11:32:31 as **
  • Proinflammatory effects of oxidative stress in chronic kidney disease: role of additional angiotensin II blockade.
    American journal of physiology. Renal physiology, Vol. 284, No. 4. (April 2003)
    by R Agarwal
    posted to acei arb ckd inflammation ros by jyuh on 2008-07-08 04:19:33 as **
  • Soluble adhesion molecules in end-stage renal disease: a predictor of outcome.
    Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, Vol. 21, No. 6. (June 2006), pp. 1603-1610.
    by ME Suliman, AR Qureshi, O Heimbürger, B Lindholm, P Stenvinkel
    posted to acei hd inflammation by jyuh on 2008-07-05 10:48:34 as **
  • Do ACE-inhibitors suppress tumour necrosis factor-alpha production in advanced chronic renal failure?
    Journal of internal medicine, Vol. 246, No. 5. (November 1999), pp. 503-507.
    by P Stenvinkel, P Andersson, T Wang, B Lindholm, J Bergström, J Palmblad, O Heimbürger, T Cederholm
    posted to acei ckd inflammation by jyuh on 2008-07-05 10:43:49 as **
  • Prevention of cardiovascular events in end-stage renal disease: results of a randomized trial of fosinopril and implications for future studies.
    Kidney international, Vol. 70, No. 7. (October 2006), pp. 1318-1324.
    by F Zannad, M Kessler, P Lehert, JP Grünfeld, C Thuilliez, A Leizorovicz, P Lechat
    posted to acei hd mortality rct by jyuh on 2008-07-04 14:35:27 as **
  • Predictors of cardiovascular events in patients with end-stage renal disease: an analysis from the Fosinopril in dialysis study.
    Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, Vol. 22, No. 12. (December 2007), pp. 3573-3579.
    by M Kessler, F Zannad, P Lehert, JP Grünfeld, C Thuilliez, A Leizorovicz, P Lechat,
    posted to acei cv hd by jyuh on 2008-07-04 14:28:21 as **
  • Use of ACE inhibitors or angiotensin receptor blockers and survival in patients on peritoneal dialysis.
    Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association (20 June 2008)
    by Wei Fang, Dimitrios G G Oreopoulos, Joanne M M Bargman
    posted to acei arb mortality pd by jyuh on 2008-07-01 03:39:38 as **
  • Sarcopenia--a potential target for Angiotensin-converting enzyme inhibition?
    Gerontology, Vol. 52, No. 4. (2006), pp. 237-242.
    by D Sumukadas, AD Struthers, ME McMurdo
    posted to acei sarcopenia by jyuh on 2008-06-29 01:46:38 as **
    • Puoi citare questa pagina come: http://www.citeulike.org/user/jyuh/tag/acei

    Result page: 1 2 Next RIS BibTeX